Literature DB >> 15866028

Aurora kinases, aneuploidy and cancer, a coincidence or a real link?

Régis Giet1, Clotilde Petretti, Claude Prigent.   

Abstract

As Aurora kinases are overexpressed in a large number of cancers, and ectopic expression of Aurora generates polyploid cells containing multiple centrosomes, it has been tempting to suggest that Aurora overexpression provokes genetic instability underlying the tumorigenesis. However, examination of the evidence suggests a more complex relationship. Overexpression of Aurora-A readily transforms rat-1 and NIH3T3 cells, but not primary cells, whereas overexpression of Aurora-B induces metastasis after implantation of tumors in nude mice. Why do polyploid cells containing abnormal centrosome numbers induced by Aurora not get eliminated at cell-cycle checkpoints? Does this phenotype determine the origin of cancer or does it only promote tumor progression? Would drugs against Aurora family members be of any help for cancer treatment? These and related questions are addressed in this review (which is part of the Chromosome Segregation and Aneuploidy series).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15866028     DOI: 10.1016/j.tcb.2005.03.004

Source DB:  PubMed          Journal:  Trends Cell Biol        ISSN: 0962-8924            Impact factor:   20.808


  99 in total

1.  Novel E3 ligase component FBXL7 ubiquitinates and degrades Aurora A, causing mitotic arrest.

Authors:  Tiffany A Coon; Jennifer R Glasser; Rama K Mallampalli; Bill B Chen
Journal:  Cell Cycle       Date:  2012-02-15       Impact factor: 4.534

2.  Aurora A inhibitor (MLN8237) plus vincristine plus rituximab is synthetic lethal and a potential curative therapy in aggressive B-cell non-Hodgkin lymphoma.

Authors:  Daruka Mahadevan; Amy Stejskal; Laurence S Cooke; Ann Manziello; Carla Morales; Daniel O Persky; Richard I Fisher; Thomas P Miller; Wenqing Qi
Journal:  Clin Cancer Res       Date:  2012-02-28       Impact factor: 12.531

Review 3.  Understanding cytokinesis failure.

Authors:  Guillaume Normand; Randall W King
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

4.  An integrated pharmacokinetic-pharmacodynamic model for an Aurora kinase inhibitor.

Authors:  Hiroko Kamei; Robert C Jackson; Daniella Zheleva; Fordyce A Davidson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2010-08-08       Impact factor: 2.745

Review 5.  Ubiquitin and SUMO systems in the regulation of mitotic checkpoints.

Authors:  Gustavo J Gutierrez; Ze'ev Ronai
Journal:  Trends Biochem Sci       Date:  2006-05-02       Impact factor: 13.807

6.  MLN8054, a small-molecule inhibitor of Aurora A, causes spindle pole and chromosome congression defects leading to aneuploidy.

Authors:  Kara Hoar; Arijit Chakravarty; Claudia Rabino; Deborah Wysong; Douglas Bowman; Natalie Roy; Jeffrey A Ecsedy
Journal:  Mol Cell Biol       Date:  2007-04-16       Impact factor: 4.272

7.  Aurora A regulates the activity of HURP by controlling the accessibility of its microtubule-binding domain.

Authors:  Jim Wong; Robert Lerrigo; Chang-Young Jang; Guowei Fang
Journal:  Mol Biol Cell       Date:  2008-03-05       Impact factor: 4.138

8.  Molecular distinctions between Aurora A and B: a single residue change transforms Aurora A into correctly localized and functional Aurora B.

Authors:  Fabienne Hans; Dimitrios A Skoufias; Stefan Dimitrov; Robert L Margolis
Journal:  Mol Biol Cell       Date:  2009-06-03       Impact factor: 4.138

9.  Transcriptional regulation of serine/threonine kinase-15 (STK15) expression by hypoxia and HIF-1.

Authors:  Alexandra Klein; Daniela Flügel; Thomas Kietzmann
Journal:  Mol Biol Cell       Date:  2008-06-18       Impact factor: 4.138

Review 10.  Alternative functions of core cell cycle regulators in neuronal migration, neuronal maturation, and synaptic plasticity.

Authors:  Christopher L Frank; Li-Huei Tsai
Journal:  Neuron       Date:  2009-05-14       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.